Facebook
Instagram
Linkedin
Pinterest
Reddit
X
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
Frequently Asked Questions (FAQ)
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
Frequently Asked Questions (FAQ)
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 22
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Faster than Your Auto-Injector: Aquestive’s Sublingual Epinephrine Film Aces New Clinical Trials
Dave Bloom
-
2026/08/10
Fecal Transplants Reveal a New Path Toward Peanut Allergy Treatment
Breakthroughs on the Horizon: FAF Funds Five New Studies Targeting Food Allergies
Next-Generation Peanut Allergy Therapy Earns FDA Fast Track Designation
As Food Allergy Treatments Become Big Business, Pharma Bets on VT-7208
BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine
Dave Bloom
-
2020/04/03
0
FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...
Dave Bloom
-
2020/03/17
0
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
0
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/22
0
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
News Wire ~ 3rd Party Press Release
-
2020/02/21
0
End Allergies Together Announces Winners of $1 Million Grand Challenge to...
News Wire ~ 3rd Party Press Release
-
2020/02/12
0
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
News Wire ~ 3rd Party Press Release
-
2020/02/06
0
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
News Wire ~ 3rd Party Press Release
-
2020/02/05
0
What You Need to Know About the First Peanut Allergy Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/03
0
FDA Approves Aimmune’s PALFORZIA as First Treatment for Peanut Allergy
News Wire ~ 3rd Party Press Release
-
2020/01/31
0
1
...
21
22
23
...
33
Page 22 of 33